FindTrial
Sign In

Construction and clinical application exploration of organoid models of gastric cancer and peritoneal metastases

Construction and clinical application exploration of organoid models of gastric cancer and peritoneal metastases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112710
Enrollment
Unknown
Registered
2025-11-18
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Gastric cancer tissue :Culture of gastric cancer tissue organoids
Gastric cancer peritoneal metastatic tissue:Culture of organoids from peritoneal metastatic tissues of gastric cancer

Sponsors

Taizhou People's Hospital, Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) 18 to 85 years old; (2) Patients who have been pathologically diagnosed with gastric cancer and confirmed to have peritoneal metastasis through surgery or laparoscopic exploration.

Exclusion criteria

Exclusion criteria: (1) Severe underlying diseases; (2) Malignant tumors in other systems; (3) Age >= 86 years old; (4) Incomplete clinical case data or lost to follow-up.

Design outcomes

Primary

MeasureTime frame
The success rate of organoid model construction;The predictive accuracy of organoid drug sensitivity testing;Improvement in clinical efficacy;—

Secondary

MeasureTime frame
Clinical case data;—

Countries

China

Contacts

Public ContactXiaolan You

Taizhou People's Hospital, Nanjing Medical University

006586@yzu.edu.cn+86 139 5114 0047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026